Table 3. Analysis of clinical variables related to gene expression.
Clinical variables | F value/X-squared | P-value |
---|---|---|
Intermediate dimension | 0.659† | 0.728 |
Longest dimension | 0.756† | 0.641 |
Shortest dimension | 0.771† | 0.629 |
New tumor event diagnosis days | 1.852† | 0.072 |
Ecog score | 1.253† | 0.279 |
Karnofsky score | 0.474† | 0.867 |
Tumor grade | 1.486† | 0.169 |
Clinical stage | 4.786† | 1.22 × 10−5*** |
New tumor event diagnosis evidence | 35.141‡ | 0.322 |
New tumor event radiation treatment | 4.876‡ | 0.771 |
New neoplasm event type | 35.491‡ | 0.307 |
Pharmaceutical treatment adjuvant | 7.03‡ | 0.533 |
Treatment outcome first course | 38.671‡ | 0.03* |
Tumor status | 17.894‡ | 0.022* |
Residual disease largest nodule | 40.183‡ | 0.02* |
Vascular invasion indicator | 7.569‡ | 0.477 |
Lymphovascular invasion indicator | 7.082‡ | 0.528 |
Anatomic neoplasm subdivision | 17.604‡ | 0.348 |
†These are quantitative variables evaluated with ANOVA for statistical analysis. The test statistic is the F value.
‡These are qualitative variables evaluated with the chi-square test. The test statistic is X-squared.
*P < 0.05.
**P < 0.01.
***P < 0.001.